Virulite LLC v Virulite Distribution Ltd & Anor [2014] EWHC 366 (QB) (26 February 2014)
The DLA was contractually varied in early 2009 to delay the £25,000 payment until FDA approval. Alternatively, the defendants waived or were estopped from relying on non-payment as grounds for termination. The notice of termination was invalid, and the defendants' purported termination was a repudiatory breach. LLC had a real or substantial chance of making profits, and damages were assessed accordingly.
- Citation
- [2014] EWHC 366 (QB)
- Parties
- Claimant: Virulite LLC; Defendant: Virulite Distribution Limited; Defendant: 1072 Technology Limited
- Jurisdiction
- England and Wales
- Judgment Date
- 26 February 2014
- Procedural Posture
- Commercial Contract Dispute / High Court Trial Judgment
- Outcome
- Judgment for the claimant
- Legal Topics
- Contract Variation, Waiver, Promissory Estoppel, Termination of Contract, Damages Assessment
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Virulite LLC
Claimant
Virulite Distribution Limited
Defendant
1072 Technology Limited
Defendant
Procedural Posture
Commercial Contract Dispute / High Court Trial Judgment
Legal Issues
- 1 Whether the Distribution and License Agreement (DLA) was contractually varied to delay the £25,000 payment until FDA approval
- 2 Whether the defendants were estopped or had waived their right to terminate for non-payment
- 3 Whether the notice of termination was valid under the DLA
Ratio Decidendi
The DLA was contractually varied in early 2009 to delay the £25,000 payment until FDA approval. Alternatively, the defendants waived or were estopped from relying on non-payment as grounds for termination. The notice of termination was invalid, and the defendants' purported termination was a repudiatory breach. LLC had a real or substantial chance of making profits, and damages were assessed accordingly.
Court Disposition
Judgment for the claimant
Orders
- Declaration that the DLA was contractually varied to delay the £25,000 payment until FDA approval
- Declaration that the defendants' termination was a repudiatory breach
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment